Glenmark Pharmaceuticals has announced that it has received marketing approval for its fixed-dose combination nasal spray, Ryaltris, in 13 countries across the UK and EU.
News
ABPI: UK’s clinical research enduring slow recovery
According to a report from the Association of the British Pharmaceutical Industry (ABPI), the UK is taking longer to recover from the COVID-19 pandemic than its European peers.
GSK’s ViiV Healthcare agrees new deal with Shionogi to develop promising HIV drugs
ViiV Healthcare, global specialist HIV company owned by GlaxoSmithKline (GSK), has announced an exclusive collaboration with Shionogi & Co Ltd (Shionogi) to develop a third-generation HIV integrase inhibitor (INSTI), with potential for ultra-long-acting dosing intervals.
UK at-home health startup raises £2 million in first round of funding
Sanome, an early-stage biotech company based in London and Cambridge, has received support from health and biotech investors from the UK and Europe in its first round of funding.
New report sheds light on medicine shortages in Northern Ireland following Brexit
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.
UK trial to evaluate existing drugs for secondary breast cancer
Trial will test if radium-223 plus avelumab can improve outcomes for metastatic breast cancer patients
New data demonstrates long-term benefit of Crysvita for XLH patients
Results showed treatment with Crysvita reduces disease burden for patients
Positive results for Lynparza plus abiraterone in metastatic prostate cancer
Interim analysis showed significant improvement in radiographic progression-free survival
Cancer care backlog in England could take ‘over a decade’ to clear, report finds
Research shows that the backlog has been ‘starkest’ in diagnostics
INTCR 2021 winners announced
The winners of the 2021 International Clinical Researcher have been announced, find out who emerged victorious.
Novartis expands gene therapy pipeline with Arctos Medical takeover
Novartis will also add Arctos’ proprietary technology to its ophthalmology portfolio
FDA OKs Pfizer/BioNTech booster doses for higher-risk populations
Earlier this week, the NHS also began offering booster jab appointments for vulnerable groups
Valneva begins COVID-19 boosters in vaccine trial
Company will also begin recruiting adolescents into Phase III vaccine trial
AZ inks agreement with saRNA specialist VaxEquity
Under the partnership, AZ will support VaxEquity with research and development funding
Amgen to collab with Verastem on KRAS combination treatment
Agreement will evaluate Verastem’s dual RAF/MEK inhibitor with Amgen’s KRAS G12C inhibitor
